The use of non-immune plasma powder in the prophylaxis of neonatal Escherichia coli diarrhoea in calves.
The protective use of plasma powder from cattle and swine against experimentally induced neonatal E. coli diarrhoea in colostrum-deprived calves was examined. Diarrhoea was induced with a strain expressing F5+ fimbriae and a strain expressing F17+ fimbriae. In all groups supplemented with bovine plasma powder, diarrhoea and fever were less severe than in the control groups. For the groups infected with the F5+ E. coli strain, a reduction in excretion of the challenge strain by 2-4 orders of magnitude and by 1-2 orders of magnitude was seen when supplemented with bovine plasma powder at a dose of 25 g/l milk and 10 g/l milk, respectively. The bovine plasma powder showed also beneficial effects in the F17+ infected groups. No mortality, no septicaemia and no severe clinical signs were observed. Concerning the excretion of the E. coli F17+ strain in the faeces, no significant difference with the control group was found. Swine plasma powder showed little beneficial effect on E. coli diarrhoea in calves in this study.
Nollet
H
H
Department of Internal Medicine and Clinical Biology of Large Animals, University of Gent, Faculty of Veterinary Medicine, Merelbeke, Belgium.
Laevens
H
H
Deprez
P
P
Sanchez
R
R
Van Driessche
E
E
Muylle
E
E
D000818:Animals; D000831:Animals, Newborn; D001422:Bacterial Adhesion; D001691:Biological Therapy; D002417:Cattle; D002418:Cattle Diseases / Q000517:prevention & control*; D003967:Diarrhea / Q000382:microbiology / Q000517:prevention & control / Q000662:veterinary*; D004926:Escherichia coli / Q000502:physiology; D004927:Escherichia coli Infections / Q000517:prevention & control / Q000662:veterinary*; D010949:Plasma; D013552:Swine